Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.220
-0.055 (-2.42%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.020 (0.90%)
After-hours: Dec 5, 2025, 7:30 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $377.26 million as of December 5, 2025. Its market cap has decreased by -76.32% in one year.
Market Cap
377.26M
Enterprise Value
225.82M
1-Year Change
-76.32%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $377.26M, a decrease of -85.40%. That is a compound annual growth rate of -57.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 370.94M | -78.34% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |